BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23666556)

  • 1. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy.
    Clippinger AK; D'Alton S; Lin WL; Gendron TF; Howard J; Borchelt DR; Cannon A; Carlomagno Y; Chakrabarty P; Cook C; Golde TE; Levites Y; Ranum L; Schultheis PJ; Xu G; Petrucelli L; Sahara N; Dickson DW; Giasson B; Lewis J
    Acta Neuropathol; 2013 Jul; 126(1):39-50. PubMed ID: 23666556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
    Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
    J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
    Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
    Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
    J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
    Riku Y; Yoshida M; Iwasaki Y; Sobue G; Katsuno M; Ishigaki S
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration.
    Taylor LM; McMillan PJ; Liachko NF; Strovas TJ; Ghetti B; Bird TD; Keene CD; Kraemer BC
    Mol Neurodegener; 2018 Feb; 13(1):7. PubMed ID: 29409526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes.
    Chen M; Ohm DT; Phillips JS; McMillan CT; Capp N; Peterson C; Xie E; Wolk DA; Trojanowski JQ; Lee EB; Gee J; Grossman M; Irwin DJ
    J Neurosci; 2022 May; 42(18):3868-3877. PubMed ID: 35318284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.
    Davis SA; Gan KA; Dowell JA; Cairns NJ; Gitcho MA
    Neurobiol Dis; 2017 Jul; 103():154-162. PubMed ID: 28416393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
    Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
    J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
    Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
    Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice.
    Xu YF; Zhang YJ; Lin WL; Cao X; Stetler C; Dickson DW; Lewis J; Petrucelli L
    Mol Neurodegener; 2011 Oct; 6():73. PubMed ID: 22029574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
    Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N
    J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.
    van Eersel J; Stevens CH; Przybyla M; Gladbach A; Stefanoska K; Chan CK; Ong WY; Hodges JR; Sutherland GT; Kril JJ; Abramowski D; Staufenbiel M; Halliday GM; Ittner LM
    Neuropathol Appl Neurobiol; 2015 Dec; 41(7):906-25. PubMed ID: 25763777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau-positive nuclear indentations in P301S tauopathy mice.
    Fernández-Nogales M; Santos-Galindo M; Merchán-Rubira J; Hoozemans JJM; Rábano A; Ferrer I; Avila J; Hernández F; Lucas JJ
    Brain Pathol; 2017 May; 27(3):314-322. PubMed ID: 27338164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.